50
Participants
Start Date
June 30, 2012
Primary Completion Date
April 17, 2017
Study Completion Date
April 17, 2017
Anti-inflammatory Combination Therapy
"1. salsalate: target dose 4 gm/day, administered in two divided doses of 2 gm in the morning and 2 gm in the evening~2. fluvastatin: target dose 40 mg/day, administered in a single evening dose~3. combined omega-3-fatty acid preparation of EPA and DHA; target dose EPA 2 gm/day and DHA 2 gm/day administered in a single evening dose"
Placebo
Non-medication pills; To be taken in morning and evening intervals.
Maryland Psychiatric Research Center, Baltimore
University of Maryland, Baltimore
OTHER